Literature DB >> 27914623

Efficacy and Safety of Omalizumab in a Patient With Chronic Spontaneous Urticaria and Active Hepatitis B Virus Infection.

P Chicharro1, P Rodríguez-Jiménez2, D de Argila2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27914623     DOI: 10.1016/j.ad.2016.10.005

Source DB:  PubMed          Journal:  Actas Dermosifiliogr        ISSN: 0001-7310


× No keyword cloud information.
  2 in total

Review 1.  Benefits and Harms of Omalizumab Treatment in Adolescent and Adult Patients With Chronic Idiopathic (Spontaneous) Urticaria: A Meta-analysis of "Real-world" Evidence.

Authors:  Michael D Tharp; Jonathan A Bernstein; Abhishek Kavati; Benjamin Ortiz; Karen MacDonald; Kris Denhaerynck; Ivo Abraham; Christopher S Lee
Journal:  JAMA Dermatol       Date:  2019-01-01       Impact factor: 10.282

2.  Omalizumab for chronic spontaneous urticaria in "complex" patients: data from real-life clinical practice.

Authors:  Laura Vollono; Arianna Piccolo; Caterina Lanna; Maria Esposito; Mauro Bavetta; Elena Campione; Luca Bianchi; Laura Diluvio
Journal:  Drug Des Devel Ther       Date:  2019-09-06       Impact factor: 4.162

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.